Plavix vs. Effient: No Consistent Winner In Real-World Data Separate analyses yield conflicting results on the same observational data
The same observational data yielded different conclusions comparing clopidogrel (Plavix) and prasugrel (Effient) use after percutaneous coronary intervention, depending on the analytic technique used by a study.